Results for the substance live attenuated yellow fever vaccine

The live attenuated yellow fever vaccine is used to prevent yellow fever, a severe viral disease transmitted by the bite of infected Aedes mosquitoes. The vaccine contains a weakened form of the yellow fever virus, which stimulates the immune system to produce specific antibodies, providing long-term protection against infection.

The vaccine is administered subcutaneously or intramuscularly, usually in a single dose, and is recommended for individuals traveling to endemic areas or living in high-risk regions. The protection provided by the vaccine lasts for at least 10 years, and in most cases, a single dose is sufficient for lifelong immunity.

Common side effects include pain at the injection site, mild fever, headache, and fatigue. In rare cases, severe adverse reactions such as allergic reactions or viscerotropic complications may occur.

The live attenuated yellow fever vaccine is an essential measure for preventing this potentially fatal disease, helping to protect public health and reduce the risk of outbreaks.